News (ZH) - LGC has today announced a further strengthening of its nucleic acid chemistry (NAC) offering with the acquisition of Berry and Associates, premier supplier of specialty oligo reagents.
News (ZH) - LINK Technologies is a premier supplier of speciality reagents for oligonucleotide synthesis
News (ZH) - Moves strengthen existing analytical and bioanalytical drug development service offering
News (ZH) - PSI products complement existing genomics offering
News (ZH) - Acquisition enables enlarged Genomics division to deliver unique product and laboratory services offering for core qPCR and end point PCR applications
News (ZH) - Exclusive license agreement relates to use of CoPrimer™ technology for both research and commercial applications.
News (ZH) - Funding to develop liver targeted gene activation therapies
News (ZH) - The new labs comprise additional bioanalysis and synthetic chemistry labs as well as a new GMP CMC analytical capability for batch release testing of oligonucleotide-based drug substances
News (ZH) - LGC will produce active pharmaceutical ingredients for preclinical and clinical study of OLX301D programme